FibroGen
A biopharmaceutical company focused on developing treatments for anemia, idiopathic pulmonary fibrosis, pancreatic cancer, Duchenne muscular dystrophy and corneal blindness
1
Funding Rounds
$6.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Je***** He******* | - | - | |
| Su***** Bl*** | - | - | - |
| Ja*** A. Sc******* | - | - | - |
| Ao*** Br***** | - | - | |
| Ma**** Ho | - | - | |
| Be****** Cr***** | - | - | - |
| En***** Co****** | - | - | |
| Ge**** Le** | - | - | - |
Funding series
Funding Series Analysis
The company FibroGen has raised a total of $6.02m in funding over 1 rounds.
Key Insights:
- FibroGen funding round, July 2012: $6.02m
FibroGen funding round, July 2012
$6.02m
Industries
FibroGen is active in the following industries:
- Biomedical engineering
- Engineering
- Technology
- Biology
- Biotechnology
- Synthetic chemistry